Results 251 to 260 of about 8,011,267 (345)

Endometrial Stromal Nodule Showing Intense Positivity for ^|^alpha;-SMA

, 2000
Yoshiki Ohta, Miki Kushima, Masaru Isozaki, Toshiyuki Mitsuya   +3 more
openalex   +2 more sources

Interplay of integrins and selectins in metastasis

Molecular Oncology, EarlyView.
Here we review the role of integrins and their interplay with selectins in metastasis. The efficacy of integrin‐targeted therapies may be reduced in tumors where metastasis relies heavily on selectins. In certain tumors, integrins and selectins exhibit a synergistic interaction during intraperitoneal dissemination.
Diana Maltseva, Ashot Nersisyan, Alexander Tonevitsky   +2 more
wiley   +1 more source

Apoptosis Inhibitor of Macrophages in Cats: A Potential Link Between an Exon 3 Variant Allele and Progression of Naturally Occurring Chronic Kidney Disease. [PDF]

J Vet Intern Med
Evangelista GCL, Hwang JK, Broughton-Neiswanger LE, Carlo Reis EC, Court MH, Mealey KA, Villarino NF.   +6 more
europepmc   +1 more source

Detection of a de novo mutation in a family with SMA Type I: The importance of dosage testing

, 2000
Jean McGowan‐Jordan, Susan Zeesman, Donald T. Whelan, P.N. Rav, Tracy Stockley, Thomas W. Prior, Nancy Carson   +6 more
openalex   +1 more source

Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry

Molecular Oncology, EarlyView.
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson, Emma L. Dorward, Kristyn Jurrius, Nathalie Nataren, Markus Tondl, Kay K. Myo Min, Michaelia P. Cockshell, Anahita Fouladzadeh, John Toubia, Mark DeNichilo, Delphine Merino, Claudine S. Bonder   +11 more
wiley   +1 more source

Efficacy of Mitochondrial Transfer in Healing Toxin-Induced Damage to Neuromuscular Junction, an Empirical Study. [PDF]

Synapse
Deschenes MR, Rackley M, Fernandez S, Heidebrecht M, Hamilton K, Paez HG, Paez CR, Alway SE.   +7 more
europepmc   +1 more source

Study on the Improvement of Cu-SMA System Performance.

, 2000
Yoshikazu Suzuki, Katsuyoshi Shimokawa, Hideki Minagawa   +2 more
openalex   +2 more sources

MET and NF2 alterations confer primary and early resistance to first‐line alectinib treatment in ALK‐positive non‐small‐cell lung cancer

Molecular Oncology, EarlyView.
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu, Ning Ding, Xiaobo Xu, Yedan Chen, Yong Zhang, Jingwen Liu, Jiebai Zhou, Hairong Bao, Donghui Zhang, Yijun Song, Yang Shao, Yuanlin Song   +11 more
wiley   +1 more source

Intuitive judgements towards artificial intelligence verdicts of moral transgressions. [PDF]

Br J Soc Psychol
Liu Y, Moore A.
europepmc   +1 more source

Fabrication of SMA Particle Dispersed Materials by Pulse Electric Current Sintering.

, 2000
Teruo Asaoka, Hiroyuki Muraoka
openalex   +2 more sources